GFACX | GXXAX | GFACX / GXXAX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 24 years | 25 years | - |
Gain YTD | 2.980 | -0.747 | -399% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 250 | 1000 | 25% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 304B | 340M | 89,412% |
Annual Yield % from dividends | 0.00 | 0.09 | - |
Returns for 1 year | 10.15 | 1.36 | 749% |
Returns for 3 years | 17.69 | 7.48 | 237% |
Returns for 5 years | 32.83 | -9.98 | -329% |
Returns for 10 years | 55.63 | -7.22 | -771% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
SHPCX | 13.13 | -0.03 | -0.23% |
Saratoga Health & Biotechnology C | |||
REIGX | 15.30 | -0.15 | -0.97% |
Federated Hermes International Growth R6 | |||
ECCPX | 47.35 | -0.98 | -2.03% |
Eaton Vance Tax-Managed Multi-Cap Gr C | |||
LEGAX | 72.01 | -1.67 | -2.27% |
Columbia Large Cap Growth A | |||
GLCRX | 28.20 | -0.67 | -2.32% |
Goldman Sachs Large Cap Gr Insghts R |